The Loteprednol Etabonate Ophthalmic Suspension is approved for use by Lupin.
MUMBAI, DEC 28 : Pharma major Lupin said that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Loteprednol Etabonate Ophthalmic Suspension, 0.2%,…